KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Biomarin Pharmaceutical (BMRN) Long-Term Debt Repayments: 2009-2015

Historic Long-Term Debt Repayments for Biomarin Pharmaceutical (BMRN) over the last 4 years, with Mar 2015 value amounting to $163,000.

  • Biomarin Pharmaceutical's Long-Term Debt Repayments rose 858.82% to $163,000 in Q1 2015 from the same period last year, while for Mar 2015 it was $1.6 million, marking a year-over-year decrease of 87.29%. This contributed to the annual value of $495.0 million for FY2024, which is N/A change from last year.
  • As of Q1 2015, Biomarin Pharmaceutical's Long-Term Debt Repayments stood at $163,000, which was down 75.19% from $657,000 recorded in Q2 2014.
  • Biomarin Pharmaceutical's Long-Term Debt Repayments' 5-year high stood at $10.4 million during Q1 2013, with a 5-year trough of -$338,000 in Q4 2011.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $735,000 (2013), whereas its average is $2.3 million.
  • Within the past 5 years, the most significant YoY rise in Biomarin Pharmaceutical's Long-Term Debt Repayments was 5,242.42% (2011), while the steepest drop was 102.42% (2011).
  • Biomarin Pharmaceutical's Long-Term Debt Repayments (Quarterly) stood at -$338,000 in 2011, then surged by 142.31% to $143,000 in 2012, then spiked by 468.53% to $813,000 in 2013, then plummeted by 99.84% to $657,000 in 2014, then surged by 858.82% to $163,000 in 2015.
  • Its Long-Term Debt Repayments was $163,000 in Q1 2015, compared to $657,000 in Q2 2014 and $17,000 in Q1 2014.